Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn L Woods

Showing results (191-200 of 259) with videos related to

Pageof 26
Sort By:
The Lancet. Healthy Longevity|February 16, 2026
The effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trialWalter P Abhayaratna, Christopher M Reid, Katherine L Webb, et al.
Geroscience|April 14, 2022
Prediction of disability-free survival in healthy older peopleJohannes Tobias Neumann, Le T P Thao, Anne M Murray, et al.
Clinical Pharmacology and Therapeutics|April 30, 2025
Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community-Dwelling Older AdultsChad A Bousman, Ankita Narang, Ziad Al Bkhetan, et al.
ERJ Open Research|February 18, 2025
Sleep apnoea, cognition and aspirin's effects in healthy older people: an ASPREE substudyStephanie A Ward, Robyn L Woods, Matthew T Naughton, et al.
BMC Medicine|July 29, 2024
Short- and long-term impact of aspirin cessation in older adults: a target trial emulationZhen Zhou, Katherine L Webb, Mark R Nelson, et al.
Gerontology|November 20, 2023
Cardiovascular Disease Risk Scores and Incident Dementia and Cognitive Decline in Older Men and WomenSwarna Vishwanath, Ingrid Hopper, Enayet Chowdhury, et al.
Archives of Gerontology and Geriatrics|March 29, 2022
The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individualsA R M Saifuddin Ekram, Robyn L Woods, Joanne Ryan, et al.
JAMA Psychiatry|June 4, 2020
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical TrialMichael Berk, Robyn L Woods, Mark R Nelson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 2, 2021
Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free SurvivalJoanne Ryan, Sara Espinoza, Michael E Ernst, et al.
JAMA Network Open|April 10, 2023
Associations of Change in Body Size With All-Cause and Cause-Specific Mortality Among Healthy Older AdultsSultana Monira Hussain, Anne B Newman, Lawrence J Beilin, et al.
Pageof 26

Showing results (191-200 of 259) with videos related to

Sort By:
Pageof 26
The Lancet. Healthy Longevity|February 16, 2026
The effects of daily low-dose aspirin on white matter hyperintensity lesions and retinal vascular calibre in healthy older adults: the ENVIS-ion exploratory neuroimaging substudy of the ASPREE randomised clinical trialWalter P Abhayaratna, Christopher M Reid, Katherine L Webb, et al.
Geroscience|April 14, 2022
Prediction of disability-free survival in healthy older peopleJohannes Tobias Neumann, Le T P Thao, Anne M Murray, et al.
Clinical Pharmacology and Therapeutics|April 30, 2025
Prevalence of Actionable Pharmacogenetic Genotype Frequencies, Cautionary Medication Use, and Polypharmacy in Community-Dwelling Older AdultsChad A Bousman, Ankita Narang, Ziad Al Bkhetan, et al.
ERJ Open Research|February 18, 2025
Sleep apnoea, cognition and aspirin's effects in healthy older people: an ASPREE substudyStephanie A Ward, Robyn L Woods, Matthew T Naughton, et al.
BMC Medicine|July 29, 2024
Short- and long-term impact of aspirin cessation in older adults: a target trial emulationZhen Zhou, Katherine L Webb, Mark R Nelson, et al.
Gerontology|November 20, 2023
Cardiovascular Disease Risk Scores and Incident Dementia and Cognitive Decline in Older Men and WomenSwarna Vishwanath, Ingrid Hopper, Enayet Chowdhury, et al.
Archives of Gerontology and Geriatrics|March 29, 2022
The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individualsA R M Saifuddin Ekram, Robyn L Woods, Joanne Ryan, et al.
JAMA Psychiatry|June 4, 2020
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical TrialMichael Berk, Robyn L Woods, Mark R Nelson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|August 2, 2021
Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free SurvivalJoanne Ryan, Sara Espinoza, Michael E Ernst, et al.
JAMA Network Open|April 10, 2023
Associations of Change in Body Size With All-Cause and Cause-Specific Mortality Among Healthy Older AdultsSultana Monira Hussain, Anne B Newman, Lawrence J Beilin, et al.
Pageof 26